VolitionRx continuing to make strong progress with another 'very, very good quarter'

Published on 10th Aug 2017

Cameron Reynolds, president and chief executive of VolitionRx Limited (NYSE MKT:VNRX), discusses with Proactive the firm's second quarter update as well as recent company highlights.

Pharma & Biotech
Add to favorites
Share with:

Related Videos


Recommended videos

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082.
You can contact us here.

Choose Proactive Region: